Key result
Long-term professional rugby career linked to depletion of 7 neuroprotective plasma EV proteins.
Why the study?
Rugby players repeatedly incur high-impact collisions predisposing them to neurodegenerative conditions, but the underlying processes and potential biomarkers indicating differences in risk across a career remain unclear.
Does a professional rugby playing career alter the plasma extracellular vesicle proteome compared to early-career players and non-collision sport athletes?
Cross-Sectional (n=24)
No
Does a professional rugby playing career alter the plasma extracellular vesicle proteome compared to early-career players and non-collision sport athletes?
p-value: p=<0.05
Long-serving professional rugby players exhibit specific depletion of neuroprotective proteins in their plasma extracellular vesicle proteome, potentially shedding light on mechanisms of heightened risk for neurodegenerative conditions.
May signal neurodegenerative risk in long-term rugby players; hypothesis-generating for EV proteome biomarkers pending validation.
Rugby players may repeatedly incur high-impact collisions that could predispose them to neurodegenerative conditions but the processes underlying the heightened risk are currently unclear. This project investigates whether the proteome of plasma extracellular vesicles (EV) could carry putative diagnostic biomarkers to indicate differences in risk to neurodegenerative conditions across a rugby playing career. Twenty-four males were recruited, including eight academy players (18 ± 1 y), eight professional rugby players (33 ± 5 y) with >10-year rugby career and eight CrossFit athletes (32 ± 5 y) with no history of collision-related sports injuries. Membrane-bound particles (i.e. EV) were enriched from plasma using hyper-porous strong-anion exchange magnetic microparticles and tryptic peptides were analysed using nano-flow liquid chromatography and high-resolution tandem mass spectrometry. Differences in protein abundance were investigated by one-way analysis of variance (with correction for multiple testing) after label free quantitation. In total, 449 proteins were confidently identified (false discovery rate; FDR <1 %) and gene ontology profiling confirmed 414 of these proteins were of EV origin. One-way ANOVA highlighted 128 significantly (P<0.05, q<0.02) different proteins across the three participant groups, of which 31 proteins were specific to professional rugby players. Seven of these proteins (APOA1, APOM, CLUS, BIP, VCAM1, NID1 and MMP9) which were depleted and one protein ZPI which was elevated have previously recognised roles in neurodegenerative processes. In conclusion, non-targeted analysis highlighted that proteins associated with neuroprotection were specifically depleted in the plasma EV proteome of long-serving professional rugby players compared to younger academy rugby players or age-matched cross-fit athletes that did not have a history of collision-related sports injuries. Our findings shed new light on processes affected by a professional rugby playing career, further application of this type of analysis could be used to develop biomarker panels useful for predicting at-risk athletes or for guiding treatment interventions.
No takes yet. Share an insight, caveat, or question.
Jagan et al. (2025) conducted a cross-sectional in Sports-related collision exposure and neurodegeneration risk (n=24). Long-term professional rugby playing career vs. Younger academy rugby players and age-matched non-contact CrossFit athletes was evaluated on Differences in protein abundance in the extracellular vesicle-enriched plasma proteome (p=<0.05). A long-term professional rugby playing career was associated with significant changes in 128 plasma extracellular vesicle proteins (P<0.05), notably including the depletion of 7 specific proteins with known roles in neuroprotection.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: